ARCH Venture Fund VIII Overage, L.P.'s Net Worth
$0
Who is ARCH Venture Fund VIII Overage, L.P.?
ARCH Venture Fund VIII Overage, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Quanterix Corp, Twist Bioscience Corp, Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..
SEC CIK
ARCH Venture Fund VIII Overage, L.P.'s CIK is 0001617237
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Metacrine, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.94M |
$13.00 |
—
| 2.94M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unity Biotechnology, Inc. (UBX) Snapshot price: $1.52
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25,308.20% | 10.01M |
—
|
—
| 10.05M |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Codiak BioSciences, Inc. (CDAKQ) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +129.73% | 5M |
$1.50 | $7,500,000.00 | 8.85M |
Sep 13
| |||
Form 4
| +75.61% | 3.79M |
$15.00 | $3,525,000.00 | 8.8M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sienna Biopharmaceuticals, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +59.61% | 2.17M |
$2.50 | $5,414,500.00 | 5.8M |
Feb 22
| |||
Form 4
|
∞
| 3.63M |
—
|
—
| 3.63M |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Homology Medicines, Inc. (FIXX) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.94% | -300.00K |
—
|
—
| 5.77M |
May 21
| |||
Form 4
|
∞
| 6.07M |
—
|
—
| 6.07M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |